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Abstract
Introduction: While most transcripts arising from the human T Cell Receptor
locus reflect fully rearranged genes, several germline transcripts have been
identified. We describe a new germline transcript arising from the human TCRB
locus.
Methods: cDNA sequencing, promoter, and gene expression analyses were used to
characterize the new transcript.
Results: The new germline transcript encoded by the human TCRB locus consists
of a new exon of 103 bp, which we namedTRBX1 (X1), spliced with the first exon of
gene segments Cß1 or Cß2. X1 is located upstream of gene segment Dß1 and is
therefore deleted from a V-DJ rearranged TCRB locus. The X1-Cß transcripts do
not appear to code for a protein. We define their transcription start and minimal
promoter. These transcripts are found in populations of mature T lymphocytes
from blood or tissues and in T cell clones with a monoallelic TCRB rearrangement.
In immature thymocytes, they are already detectable in CD1aCD34þCD4CD8
cells, therefore before completion of the TCRB rearrangements.
Conclusions: The X1 promoter appears to be the ortholog of the mouse pre-Dß1
promoter (PDß1). Like PDß1, its activation is regulated by Eß in T cells and might
facilitate the TCRB rearrangement process by contributing to the accessibility of
the Dß1 locus.
Introduction
T cell receptor (TCR) gene rearrangements are complex
multistep processes occurring at different stages of thymocyte
maturation. They involve double-strand DNA breaks at the
recombination signal sequences that border the V(D)J gene
segments and that are recognized by the RAG1/RAG2
recombinases [1]. The process is tightly controlled, with the
TCRB locus being rearranged before TCRA. For TCRB it
occurs in two steps. First, at the CD4CD8 double negative
stage a Dß gene segment recombines with a Jß segment
yielding a Dß.Jß partially rearranged genomic DNA. These
early rearrangements occur at the CD1þCD34þ stage. In a
second step, ending before the CD4þCD8þ double positive
(DP) stage, a Vß gene segment recombines with Dß.Jß [2]. If
this rearrangement leads to the production of a complete
TCRB chain, the latter dimerizes with the pre-TCRA chain
and initiates ß-selection. During ß-selection, the pre-TCR
signaling suppresses RAG1/2 expression, induces several
rounds of division anddifferentiation towardCD4þCD8þDP
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thymocytes. At the DP stage, reexpression of RAG1/2 enables
TCRA rearrangements to produce TCR-positive DP cells [3].
Our previous work on T lymphocytes infiltrating human
melanoma tumors led us to construct TCRB cDNA
libraries [4]. Starting from tumoral RNA, we first used a
SMART-PCR on cDNA extended from a Cß primer, and
cloned the amplified products. Sequencing these products
provided information on frequencies of tumor-specific
cytolytic T cell clones present in the tumor [4]. A significant
proportion of the sequences corresponded to a new TCRB
germline transcript that we describe here.
Materials and Methods
Construction of TCRB-targeted cDNA libraries
These libraries [4] were built up from RNA reverse-
transcribed with an antisense Cß primer [nt 63–47 of exon
1] in the presence of SMART II (Clontech1, Mountain View,
CA, USA) [5], an oligonucleotide engineered to be copied at
the 30-end of the growing cDNAduring reversion, ought to an
intrinsic Terminal deoxynucleotidyl Transferase (TdT)
activity of the RT. A RNaseH RT-enzyme in an appropriate
buffer is needed for this 30-extension of the cDNA. With a
primer consisting in the core of the SMART primer (50-
gcagtggtaacaacgcagagta) and a Cß primer (primer 2 of
Table 1) locatednear the 50 endofCß, the cDNAwasamplified
by PCR for a limited number of cycles with an annealing step
at 608C. Products shorter than 150 bp were removed by a
Sepharose CL-6B size-exclusion column (Pharmacia-Amer-
sham).Under these conditions, the products derived from full
length TCRB (TRB-LVDJC) transcripts are in the range of
480 bpwith 33 nucleotides coming from the primed region of
Cß. Using a small fraction of the extracted RNA, in order to
obtain the ‘‘smarted’’ cDNA from 0.5–1% of the TCRB
transcripts, allows to estimate the frequency of the most
prevalent clonotypes present in that sample, assuming a copy
number of 200 productiveTRB-LVDJC transcripts/T cell. The
method also allows to readily define the 50-ends of the TCRB
transcripts, as an alternate 50-RACE approach, since many of
the isolated clones represent full length cDNA.
Detection of X1-Cß transcripts by RT-PCR
For the detection of X1-Cß transcripts in T cell clones,
Epstein-Barr virus-transformed B cell lines, tumor lines or
fresh PBMC, RNA was extracted without DNAse pretreat-
ment, by the TRIPure method (Roche1) and cDNA was
readily obtained by reverse-transcription of 1mg of total
RNA for 1 h at 428C with 100UI SmartScribe1 RT of
Clontech, the SMART II primer (1mM) and an anchored-
dT21 primer (2.5mM) in a volume of 10ml. After an
inactivation step at 708C for 15min, the cDNAs were
diluted with water to 50ml and stored at 208C. PCR
products of 227 bp were obtained from 2.5ml of cDNA
(derived from 50 ng RNA or 2500–10,000 cells) with
Table 1. Primers used for X1-Cß transcripts quantiﬁcation.
Sequence Target Position
50-GCTCAAAACATCCTGAGGACA (#1 in Fig. 2A) X1 sense 73–93a
50-CGACCTCGGGTGGG (#2 in Fig. 2A) Cß antisense 33–16b
50-TGCTCCTTGAGGGGCTGCG (#3 in Fig. 2A) Cß antisense 196–178b
50-FAM-TTCAGGTCCTCTCCAGGCACTG-TAMRA (P in Fig. 2A) X1Cß probe, antisense straddling X1 and Cß
50-ATTGCCGACAGGATGCAGAA ACTB sense 998–1017c
50-GCTGGAAGGTGGACAGCGA ACTB antisense 1133–1115c
50-TGCTCCTTGAGGGGCTGCG ACTB probe 1053–1078c
50-GGAGGCTATCCAGCGTACT B2M sense 114–132c
50-GACCAGTCCTTGCTGAAAGACA B2M antisense 302–281c
50-CGGATGGATGAAACCCAGACACATAGC B2M probe 220–194c
50-GCTTCACTGCTCAGGTGAT EEF1A1 sense 1079–1097c
50-GCCGTGTGGCAATCCAAT EEF1A1 antisense 1160–1143c
50-AAATAAGCGCCGGCTATGCCCCTG EEF1A1 probe 1118–1141c
50-GGTGTGAACCATGAGAAGTATGA GAPDH sense 502–524c
50-GATGGCATGGACTGTGGTCA GAPDH antisense 645–626c
50-CCTCAAGATCATCAGCAATGCCTCCTG GAPDH probe 531–557c
To exclude genomic signals, in each amplicon either one primer or the probe straddles two exons. Double dye probes obtained from Eurogentec (Liege,
Belgium) are 6-FAMmarked in 50 and quenched in 30 with TAMRA. All qPCR ampliﬁcationswere performed on the same dT-primed cDNA templates with
sense primers located at similar distances from the poly-A tail (785, 796, 874, 669, and 809 nt forX1-Cß,ACTB, B2M, EEF1A1, andGAPDH, respectively).
aPositions are relative to the TSS of exon X1.
bPositions given from the 50-end of exon 1 of Cß1 and Cß2
cPositions given according to the reference mRNAs: NM_001101.2 for ACTB; NM_004048 for B2M; NM_001402 for EEF1A1; NM_002046.3 for
GAPDH.
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primers 1 (X1 sense), and 3 (Cß antisense, Fig. 2A and C
and Table 1) and 0.625UI of conventional Taq DNA
polymerase (Takara) in a final volume of 25ml, with 35
cycles (annealing at 608C). These products were analyzed
by gel electrophoresis and sequenced. To quantify the
expression levels of X1-Cß, amplified products of 64 bp
were obtained from the same amounts of cDNA with
primers 1 and 2 (Table 1 and Fig. 2A), Hot Start Taq DNA
Polymerase (Eurogentec, Liege, Belgium), annealing and
extension at 628C on a StepOnePlus thermocycler (ABI),
and quantified with a FAM-TAMRA Double Dye probe
(Eurogentec) straddling X1 and Cß exon 1. Expression
levels were normalized with ACTB and expressed as X1-
Cß/ACTB ratios obtained from DCq at identical thresh-
olds, with verified amplification yields of 95% for both
qPCR. We compared the levels of expression of the
housekeeping genes ACTB, GAPDH, EEF1A1, and B2M in
our samples [6] with the probe and primers indicated in
Table 1, and observed the best correlations between the
numbers of cells and ACTB expression levels.
X1 promoter cloning
Gene segments of 1125, 943, 242, 95, and 48 bp located
upstream of the major Transcription Start Site (TSS) of
exon X1 were obtained by PCR and cloned in Firefly
luciferase vector pGL4.15 (Promega, Fitchburg, WI, USA),
using Q5 (New England Biolabs) or the high fidelity DNA
polymerase Pfu (Stratagene, La Jolla, CA, USA) mixed with
Takara Taq. In the same experiments, we used a 187 bp
sequence upstream of the TRBV7.2 TSS, as a control
promoter. In addition, a 400 bp fragment of the Enhancer
ß (Eß) comprising the Eß-core [7] was cloned in the
unique BamH I site of pGL4.15 vectors containing the
943 bp fragment of the X1 promoter or the 187 bp-long
Vß7.2 promoter. The constructs were co-transfected in
triplicates in either HEK293T or Jurkat E6.1 cells with
pGL4.75, a plasmid expressing the Renilla luciferase driven
by a CMV promoter, as a transfection efficiency control.
We used Lipofectamine 2000 (Invitrogen, Carlsbad, CA,
USA) and TransIT1Jurkat (Mirus Bio LLC) to transfect
HEK293T and Jurkat cells, respectively. Luciferase activi-
ties were measured after 24–40 h using the Dual-Glo1
Luciferase Assay System (Promega) and a Glomax Discover
plate reader (Promega). The Firefly luciferase activity was
normalized to that of the Renilla luciferase and the results
compared to those obtained with a promoterless vector,
providing the ratios shown in Figure 3A.
Isolation of human thymocytes
Postnatal thymuses were obtained from 0- to 12-year-old
children that underwent cardiac surgery. Cord blood was
obtained from the Navelstrengbloedbank UZ Gent. All
human material was used following guidelines of the
Medical Ethical Committee of the Ghent University
Hospital (Belgium). Informed consent was obtained in
accordance with the Declaration of Helsinki. A thymocyte
suspension was made within 24 h after surgery. Cord blood
mononuclear cells were obtained after density centrifuga-
tion. CD34þ cells were enriched by anti-CD34 magnetic
activated cell sorting (MACS Miltenyi Biotec) to a purity of
>90% and subsequently labeled and sorted in
CD34þCD1CD3CD45þ and CD34þCD1þCD3CD45þ.
CD4iSP (CD1þCD45þCD4þCD3CD8) and DP (CD3þ
CD4þCD8þ) cells were sorted without pre-enrichment
procedures. Anti-CD45, CD34, CD1, CD3, CD4,
and CD8a antibodies used for sorting were obtained
from Miltenyi Biotech. The cells were sorted on a
FACSAria II to a purity of >99%. RNA and cDNA were
obtained as described above.
Sequence analyses
To identify potential target sites of transcription factors
within the X1 promoter, we used the JASPARdatabank 2016,
with a 0.85 threshold score (http://jaspar.genereg.net/cgi-
bin/jaspar_db.pl?rm=browse&db =core&tax_group =verte
brates). DNase I Hypersensitive sites were predicted with the
ENCODE project at http://www.genome.ucsc.edu/.
Results
A new germline TCRB transcript contains a
previously undescribed exon
Starting from RNA extracted from eight melanomas that
were infiltrated by T lymphocytes, we produced eight TCRB
cDNA libraries using a TCR-Cß reverse primer and the
SMART oligonucleotide (Clontech). We sequenced about
1900 cDNA clones from these libraries. About 75% of the
sequences corresponded to TCRB sequences: 65% were
in-frame rearranged TCRB sequences with a median length
of 420 bp, 15% were J-C sequences apparently initiated in
front of Jß2.3 (ENA LT626065) and other Jß gene segments,
10% were very short J-C products, and 5–10% were
sequences of 140 nucleotides, containing a Cß1 (60%) or
Cß2 (40%) sequence preceded by 103 nucleotides not
reported to be present in TCRB transcripts. In the human
TCRB locus, this 103 bp sequence ends 174 nucleotides
upstream of the Dß1 gene segment. It is preceded by a
potential TATA box and followed by a predicted [8] donor
site of splicing (Fig. 1). These results suggested that this
103 nt sequence was the first exon, which we named TRBX1
(X1), of a new germline TCRB transcript that contained X1
and Cß sequences.
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To identify the 30 end of these X1-containing transcripts,
RNA was extracted from 3 T cell clones and reverse-
transcribed with an anchored oligo-dT primer. The resulting
cDNA was used as a template for a PCR amplification with
the anchor and primer 1 in exon X1 (Fig. 1) and the
amplified products were sequenced. The sequences were
about 860 bp long and corresponded to X1 spliced either
with the first exon ofCß1 followed byCß1 exons 2–4, or with
the first exon of Cß2 followed by Cß2 exons 2–4. All
sequences had a 30 polyA tail. The structure of the X1-Cß
transcripts is shown in Figure 1.
X1-Cß gene products can only be transcribed from TCRB
loci that have not undergone a V-DJ rearrangement, as the
latter deletes X1 (Fig. 1). We surmised that X1-Cß1
transcripts originated from TCRB loci either in germline
configuration or with Dß1-Jß1 rearrangements. Indeed, the
first good acceptor site of splicing downstream of X1 is that
of Cß1 exon 1. In case of Dß1-Jß2 rearrangements, Cß1 is
deleted and the next good acceptor site is that of Cß2 exon 1.
We confirmed this hypothesis by establishing the TCRB
genomic structure and Cß usage of the X1-Cß transcripts on
a set of 12 T cell clones with a single V-DJ rearrangement. As
expected, no X1-Cß transcripts were detected in the three
clones with two V-DJ rearrangements (data not shown).
Exon X1 contains no ATG initiation codon and is
therefore not expected to be translated. Translation of a
protein from the Cß segment of X1-Cß appears unlikely. The
largest ORF is 141 nt long and ends 53 nt upstream of the
exon 3/exon 4 junction. It is preceded by very short ORFs, a
feature that disfavors its translation. In addition, translation
ending in the second last exon at a distance greater than
50–55 nt from the last exon-exon junction complex
precludes the ribosome from removing the complex which
then recruits RNAses and ubiquitin [9]. We provisionally
conclude that the X1-Cß transcripts are sterile.
We conclude to the presence in human T lymphocytes of
previously undescribed TCRB mRNAs that contain
860 nt and consist of a new exon, X1, followed by Cß1
or Cß2 exons.
Expression of X1-Cß transcripts
We screened various cell types using a RT-qPCR amplifica-
tion with primers 1 and 2 located in X1 and Cß, respectively,
and a probe straddling the X1-Cß junction (Fig. 2A and
Table 1). From a set of 44 T cell clones previously established
in our laboratory, only 24 (55%) expressed X1-Cß tran-
scripts (Fig. 2B). This proportion was expected: X1 is lost
during the V-DJ recombination process and X1-Cß tran-
scripts are therefore absent from T cells that have undergone
bi-allelic TCRB rearrangements. In murine lymph node-
derived T cells, the proportion of cells with a single
rearranged TCRB locus was estimated at 57% [10]. X1-Cß
transcripts could also be detected in about 50% of T cell
clones using a conventional RT-PCR yielding a larger
amplicon whose sequence could be verified (Fig. 2C). In
cultured T cell clones, we estimated the levels of expression
of X1-Cß and complete TCRB transcripts at 2–10 and 100–
300mRNAmolecules per cell, respectively [11] and data not
shown). Thus in mature T cells the number of X1-Cß
transcripts is considerably lower than that of the TCRB-
encoding mRNAs.
Figure 1. Exon X1 within the human TCRB locus. Representation of the 30 end of the unrearranged TCRB locus with the location of exon X1. The
structure of the twomost abundant germlineX1-Cß transcripts is indicated. The complete sequence of X1 (103 bp) is boxed. A TATA box and a donor site
of splicing (DS) are indicated. Primer 1 in X1 was used in PCR ampliﬁcations. Sequences are accessible at European Nucleotide Archive: Exon X1
(LT601549) and X1-Cß1 transcript (LT601550).
New human TCRB transcript B. Lethe et al.
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We detected X1-Cß expression in freshly isolated blood
CD4 or CD8 T cells, in Phytohemagglutinin-A activated
blood T cells and in leukemic T cells including Jurkat E6.1.
No expression was detected in non-T cells such as
fibroblasts, keratinocytes, monocytes, CD34þ cord blood
cells, Epstein-Barr virus-transformed B cells and 35 tumor
lines from various non-T histological types (Fig. 2B and data
not shown).
In sorted sub-populations of thymocytes, X1-Cß expres-
sion increased concurrent with ß-selection: expression was
low in pre-ß selection CD34þCD1a and CD34þCD1aþ
double negative (DN) cells (Fig. 2B) and 10-times higher in
post-ß selection CD3CD4þ (immature single positive cells:
iSP4) and CD3þCD4þCD8þ DP populations (Fig. 2B).
We conclude that X1-Cß transcripts are T cell-specific and
appear when TCRB gene rearrangements are initiated. They
are absent from T cells with biallelic V-DJ rearrangements.
A promoter sequence in front of X1
To examine the regulatory elements governing X1 transcrip-
tion, we cloned the genomic DNA immediately upstream of
X1 in a luciferase-encoding vector and transfected the
construct into HEK293T cells. We compared the promoter
activities of five sequences of decreasing sizes (Fig. 3A). The
highest promoter activities were observed for the two largest
fragments, of 1125 and 943 bp, with similar inductions of 23-
and 21-fold versus that of the promoterless construct. These
inductions were approximately sixfold lower than that
observed with a Vß7.2 promoter (Fig. 3A). An antisense
construct of 943 bp had no activity (Fig. 3A). The shortestX1
promoter fragment with a detectable activity was 95 bp long
(7.5-fold induction).
We also transfected several of these constructs in the
leukemic T cell clone Jurkat E6.1, with or without the 393 bp
core sequence of the TCRB gene enhancer (Eß) which was
shown to enhance the transcription of several TRBV
genes [7]. Transfection of the 943 bp long X1 promoter
with Eß stimulated transcription (Fig. 3A). However, in the
absence of Eß the stimulation of transcription was minimal,
which was expected considering the role of Eß for TCRB
transcription in T cells.
We conclude that a promoter sequence is present
immediately upstream to the X1 sequence. In line with
Figure 2. Expression of X1-Cß. (A) Schematic representation of the primers used in quantitative (B) and conventional (C) X1-Cß RT-PCR assays. Arrows
and bar indicate primers and probe listed in Table 1. (B) Levels of X1-Cß expression were measured by RT-qPCR using primers 1, 2, and probe P on cDNA
obtained from T cell clones, freshly isolated T cells, Phytohemagglutinin-A stimulated blood lymphocytes, acute T cell leukemias, Epstein-Barr virus-
transformed B cells, ﬁbroblasts, and CD34þ cord blood cells, tumor lines (7 melanomas and 1 sarcoma) and thymocytes at various maturation stages:
CD4þCD8þ double positive (DP), immature CD4þ single positive (iSP4), CD4CD8 double negative (DN) CD1aþ or CD1a. Results are presented as X1-
Cß/ ACTB ratios calculated as indicated inMaterials andMethods. (C) Gel analysis of ampliﬁed products obtainedwith a conventional PCR using primers 1
and 3 on cDNA obtained from 5 T cell clones. RNA integrity was assessed by amplifying GAPDH and ACTB cDNAs in a parallel duplex PCR for 22 cycles.
Lane 6 is a 1 kb ladder (Invitrogen).
B. Lethe et al. New human TCRB transcript
© 2017 The Authors. Immunity, Inflammation and Disease Published by John Wiley & Sons Ltd. 5
this conclusion, a DNAse I hypersensitivity region straddling
the TSS of X1 is observed almost exclusively in T cells,
according to the ENCODE project (Fig. 3B and Materials
and Methods). Moreover, in T cells the X1 promoter is
controlled by Eß.
The sequence of the X1 promoter followed by X1 appears
to be the human ortholog of the murine Dß1 Promoter
(PDß1), a 377 bp sequence located immediately upstream of
the TRBD1 gene segment [12] (Fig. 3B). Actually, this 377 bp
sequence appears to consist in a promoter followed by the
first 200 nt of germline transcripts controlled by this
promoter. Indeed, reported transcripts contain the PDß1
last 200 nt sequence followed byDß1 usually rearranged with
a Jß spliced to aCß segment [13] (andmurine EST database).
Figure 3. Characterization of the X1 promoter region. (A) Genomic DNA fragments of indicated sizes, immediately preceding the TSS of exon X1, were
cloned in front of the Fireﬂy luciferase gene in vector pGL4.15, with or without Eß as indicated. The constructs were co-transfected in HEK293T cells or
Jurkat cells with vector pGL4.75 containing the Renilla luciferase sequence. Control constructs included pGL4.15 without promoter, with a X1 promoter
sequence cloned antisense (as) and with a Vß7.2 promoter sequence. One day after transfection, both luciferase activities were measured. The results,
means of 2–9 independent assays, are expressed relatively to those obtained with the pGL4.15 promoterless construct. Sequence of the 1125 bp
promoter fragment: ENA LT601551. (B) Sequence homologies between the human and murine pre-Dß1 regions. Promoter and transcribed sequences
are shown as closed and open boxes, respectively. The PDB1 sequence proposed here is shorter at its 30-end than in the original description by Sikes [12],
taking into account the longest germline transcripts reported by Doty [13] or present in Genbank (EST CB598216, and BB587363). The indicated DNase I
hypersensitivity region straddling the TSS of X1 is described for human T cells by the ENCODE project.
New human TCRB transcript B. Lethe et al.
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The homology between the human and murine DNA
sequences upstream of Dß1 is above 70% immediately 50 to
Dß1, remains at 60% for X1, and the last 135 bp of its
promoter, then drops sharply to 40% for upstream
sequences (Fig. 3B).
Sp1 and GATA3 have been shown to contribute to PDß1
activity [12] and binding sites for these transcription factors are
present also in theX1 promoter. SevenGATA3 sites are present
upstream of the human and murine Dß1 sequences (Fig. 4).
While a single and important Sp1 site is present in the mouse,
three sites are present in the X1 promoter (Fig. 4). Interestingly,
16 nucleotides positioned 91–77 nt upstream to the TSS of X1
are perfectly conserved between human andmurine sequences.
They are contained in the 377 bp core PDß1 promoter reported
by Sikes [12]. They contain no GATA3 or Sp1 site, but a
consensus AP-1 site indicated with arrows on Figure 4. This
AP-1 site might participate together with an Sp1 site in the
promoter activity present between nucleotides48 and95 of
the human X1 promoter (Fig. 3A).
Discussion
In the mouse, several germline transcripts have been
described that originate from the IG and TCR
loci [14–16]. They are usually expressed, when the gene
segments from which they are derived are poised to
rearrange [17]. IG and TCR germline transcriptions have
been considered as facilitating gene segment rearrangements
by contributing to the accessibility of the loci to the
recombinase complex [18], as deeply reviewed by Oltz and
colleagues [19, 20].
For the TCRB locus, the best-studied germline transcrip-
tion occurs upstream of the murineDß1 gene segment and is
controlled by a promoter named PDß1 [12]. The accessibility
of Jß1, Dß2-Jß2, and the proximal Vß gene segments is
controlled by the enhancer Eß [14], but both Eß and PDß1
are required for Dß1-Jß rearrangements to occur [21].
Deletion of PDß1 or its displacement downstream toward
Jß1 was shown to prevent Dß1-Jß recombinations [21, 22].
However, Dß1-Jß recombinations persisted after PDß1
inversion, indicating that it is not the germline transcription
through the Jß segments that is important for Dß1-Jß
recombination [22]. Finally, mutations of GATA3 or Sp1
binding sites within PDß1 strongly impaired Dß1 recombi-
nations [12, 13]. Thus, like Eß, PDß1 is an accessibility control
element (ACE), even though it controls a much shorter
genomic interval than Eß does. The accepted model is that
the interaction of PDß1 with Eß leads to the recruitment of
additional factors that ultimately favor recombination by
locally reorganizing the chromatin structure. One of these
factors is a component of the SWI/SNF complex, which is
required in murine thymocytes to open theDß1 region prior
to recombination [23].
Very little is known about IG andTCR germline transcription
in human cells [24, 25]. We describe a new germline transcript
from the human TCRB locus, with a new exon, X1, located
upstream of Dß1 and spliced with the first exon of Cß1 or Cß2.
X1-Cß transcription is controlled by a promoter that appears to
be the ortholog ofPDß1, for two reasons. First, both are localized
in front of germline transcripts initiated in the pre-Dß1 region.
Indeed in themouse, thePDß1 sequences describedby Sikes [12]
and Whitehurst [21] contain more than a promoter, as their 30
halves can be transcribed [13] (and Genbank EST database).
Accordingly the core promoter in PDß1 is less than 200bp long
and starts 377bpupstreamofDß1 (Fig. 3B). In thehumanTCRB
locus, the shortest tested sequence with X1-promoter activity is
Figure 4. Transcription factor binding sites upstream of human andmurineDß1.Human andmurine genomic DNA regions upstream of Dß1 are shown
with predicted positions of transcription factors GATA3, SP1, and AP-1 (scores 0.85 in the JASPAR data bank of target sequences for transcription
factors of vertebrates, 2016). Arrow heads indicate reported starts of transcription. Vertical lines show the 50-ends of the X1 promoter fragments
analyzed in Figure 3A. Small arrows indicate an AP-1 site present within a 16 nt stretch that is perfectly conserved between the human and murine
sequences.
B. Lethe et al. New human TCRB transcript
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95bp long and starts 371bp upstream of Dß1. Second, the 410
nucleotides upstream of murine and human Dß1 are homolo-
gous. The homology is maximal (77%) next to Dß1, is
maintained at about 60%until the 50 end of the core promoters,
then drops sharply to 40% (Fig. 3B).
In line with their role of ACEs, the murine PDß1 and the
human X1 promoter are activated at the earliest stages of
thymocyte maturation, that is prior to Dß rearrangements.
Indeed, PDß1-controlled transcripts have been detected in
thymocytes of Rag/ animals [13, 14], and we have detected
X1-Cß transcripts in human CD34þ CD1a CD4 CD8
CD45þ (DN) thymocytes, which contain no proteins with a
Cß1 domain [26] and very few if any Dß-Jß recombination
products [2].
Our results suggest that X1-Cß expression is 10-times
higher in late stages of thymocyte differentiation (iSP4 and
DP) than in earlier stages (DN). The timeframe for V-DJ
rearrangements at the human TCRB locus extends until the
DP stage [2, 3, 26, 27]. Accordingly, a high level of X1-Cß
transcription at the time of V-DJ recombination may
contribute to this stochastic process by increasing the
accessibility of the 50RSS of the recombining Dß1 gene
segment. Mutations in X1 promoter might cause biases in
the TCR repertoire, with a higher proportion of Vß-Dß2
rearrangements.
We observed that X1-Cß expression persisted in mature T
cells without two complete TCRB rearrangements. This
persistence contrasts with what has been observed for other
IG or TCR germline transcripts such as J-Ck, I-Cm, T early
alpha (TEA), and Vß, which are expressed mainly in
immature lymphocytes [18, 28, 29].
X1-Cß was also expressed in some acute B cell leukemias
(data not shown). This expression is linked to an accessible
TCRB locus leading to an incomplete ß-rearrangement
process [30–32]. X1-Cß is expressed at low levels in the
erythroleukemia line K562, which is one of the rare non-T
cell lines with some DNase I hypersensitivity around the TSS
of X1 (ENCODE project).
Allelic inclusion at the TCRB locus, that is leading to the
presence of two functional TCRß chains on the cell surface,
has been reported to occur in about 1% of human T cell
clones, suggesting that allelic exclusion at this locus is not an
absolute rule [33, 34]. The difficulty of these genetic analyses
is to ensure that the analyzed cell populations are clonal. In
this context, an RT-PCR assay for X1-Cß can help: in a given
clone the detection of X1-Cß transcripts excludes the
presence of two complete TCRß rearrangements (except
for the rare Vß30-Dß2-Jß2 rearrangements).
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